The European CLL Association (ECLLA) has published its European Policy Brief 2026, setting out key priorities and recommendations to help address inequalities in chronic lymphocytic leukaemia (CLL) care across Europe. The Brief was formally launched on 30 September...
Dear members and friends, We are pleased to invite you to join us for Blood Cancers and CLL on the European Agenda: From Recognition to Action, a high-level multi-stakeholder policy dialogue hosted by MEP Regina Doherty and organised by the European CLL Association...
European CLL Association – ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the...
ECLLA is deeply grateful to Dr Brian Koffman, MDCM (retired) MS Ed, Co-Founder and Chief Medical Officer Emeritus, CLL Society Inc., and member of European CLL Association – ECLLA Medical Advisory Board, for bringing both professional expertise and lived...
ECLLA is proud to work alongside Prof Amanda Kracen, Professor of Psychology and Counselling Psychologist, whose expertise brings an essential perspective to our Medical Advisory Board. At the ECLLA Policy Roundtable in Dublin this May, Prof Kracen highlighted a topic...
ECLLA is incredibly grateful to have Dr Ben Kennedy, Consultant Haematologist at Cork University Hospital, Ireland, as a member of our Medical Advisory Board. At the ECLLA Policy Roundtable in Dublin this May, Dr Kennedy shared valuable insights into one of the most...